Samay

Samay is a private, early-stage digital health company building an AI/ML platform to enable personalized chronic disease management. Operating in the high-growth digital therapeutics and remote patient monitoring space, the company is likely pre-revenue and focused on platform development and validation. Its success will hinge on demonstrating clinical efficacy, securing regulatory pathways, and achieving integration within existing healthcare systems against established competitors.

AI and machine learning platform that integrates multimodal patient data to enable personalized care interventions and continuous monitoring for chronic diseases.

Samay competes in the crowded digital therapeutics and chronic care management space, facing competition from pure-play DTx companies (e.g., Omada Health, Livongo), large healthcare IT vendors (e.g., Teladoc, Philips), and tech giants (e.g., Google Health, Apple) investing in health AI. Differentiation requires superior clinical validation and seamless integration.